Azitra Inc(AZTR) - 2024 Q2 - Quarterly Results

Exhibit 99.1 Azitra, Inc. Announces Q2 2024 Financial Results and Provides Business Updates BRANFORD, Conn. — Azitra, Inc. (NYSE American: AZTR), a clinical-stage biopharmaceutical company focused on developing innovative therapies for precision dermatology, today reported financial results for the three months ended June 30, 2024, and provided a business update. Q2 2024 and Recent Business Highlights ● Completed a follow-on offering of $10 million in gross proceeds expected to provide cash runway into 2025 ...